{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:13:43Z","timestamp":1761664423847,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.vaccine.2022.05.071","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T07:20:59Z","timestamp":1655536859000},"page":"4580-4593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Previous biological therapy and impairment of the IFN-\u03b3\/IL-10 axis are associated with low immune response to 17DD-YF vaccination in patients with spondyloarthritis"],"prefix":"10.1016","volume":"40","author":[{"given":"Thays Zanon","family":"Casagrande","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismael Artur da","family":"Costa-Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Bernadete Renoldi de Oliveira","family":"Gavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira Tatiyama","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscila Costa","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9rica Vieira","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valquiria Garcia","family":"Dinis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketty Lysie Libardi Lira","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia Alves","family":"Gouvea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa Carvalho","family":"Caser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Carolina","family":"Campi-Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9a","family":"Teixeira-Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Peruhype-Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria de Fatima","family":"Bissoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria da Penha Gomes","family":"Gouvea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila Maria Barbosa de","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily Hime","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisela Freitas","family":"Trindade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle Grillo Pacheco","family":"Lyra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula Neves","family":"Burian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauro Ferreira da Silva Pinto","family":"Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Licia Maria Henrique","family":"da Mota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olindo Assis","family":"Martins-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9ria","family":"Valim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.05.071_b0005","doi-asserted-by":"crossref","unstructured":"Monath TP, Vasconcelos PF. Yellow fever. J Clin Virol 2015;64:160-73. https:\/\/doi.org\/10.1016\/j.jcv.2014.08.030.","DOI":"10.1016\/j.jcv.2014.08.030"},{"issue":"11","key":"10.1016\/j.vaccine.2022.05.071_b0010","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.tim.2018.05.012","article-title":"Yellow fever virus: knowledge gaps impeding the fight against an old foe","volume":"26","author":"Douam","year":"2018","journal-title":"Trends Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.071_b0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2007.10.009","article-title":"Treatment of yellow fever","volume":"78","author":"Monath","year":"2008","journal-title":"Antiviral Res"},{"issue":"10","key":"10.1016\/j.vaccine.2022.05.071_b0020","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3201\/eid2210.160818","article-title":"Resurgence of yellow fever in Angola, 2015\u20132016","volume":"22","author":"Grobbelaar","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"15","key":"10.1016\/j.vaccine.2022.05.071_b0025","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMp1702172","article-title":"Yellow fever - once again on the radar screen in the Americas","volume":"376","author":"Paules","year":"2017","journal-title":"N Engl J Med"},{"issue":"6405","key":"10.1016\/j.vaccine.2022.05.071_b0030","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1126\/science.aat7115","article-title":"Genomic and epidemiological monitoring of yellow fever virus transmission potential","volume":"361","author":"Faria","year":"2018","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2022.05.071_b0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1586\/erv.12.6","article-title":"Review of the risks and benefits of yellow fever vaccination including some new analyses","volume":"11","author":"Monath","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2022.05.071_b0040","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1590\/S0034-89102004000500009","article-title":"Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial","volume":"38","author":"Camacho","year":"2004","journal-title":"Rev Saude Publica"},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.071_b0045","doi-asserted-by":"crossref","first-page":"e001035","DOI":"10.1136\/rmdopen-2019-001035","article-title":"Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations","volume":"5","author":"Rondaan","year":"2019","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.071_b0050","doi-asserted-by":"crossref","DOI":"10.1186\/s42358-019-0056-x","article-title":"Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases","volume":"59","author":"Pileggi","year":"2019","journal-title":"Adv Rheumatol"},{"key":"10.1016\/j.vaccine.2022.05.071_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01382","article-title":"Planned yellow fever primary vaccination is safe and immunogenic in patients with autoimmune diseases: a prospective non-interventional study","volume":"11","author":"Valim","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.071_b0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-89770-8","article-title":"Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination","volume":"11","author":"da Costa-Rocha","year":"2021","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2022.05.071_b0065","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.vaccine.2007.12.035","article-title":"Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination","volume":"26","author":"Martins","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.05.071_b0070","doi-asserted-by":"crossref","unstructured":"Costa-Pereira C, Campi-Azevedo AC, Coelho-Dos-Reis JG, Peruhype-Magalh\u00e3es V, Ara\u00fajo MSS, do Vale Antonelli LR, et al. Multi-parameter approach to evaluate the timing of memory status after 17DD-YF primary vaccination. PLoS Negl Trop Dis 2018;12(6):e0006462. https:\/\/doi.org\/10.1371\/journal.pntd.0006462.","DOI":"10.1371\/journal.pntd.0006462"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.071_b0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.071_b0080","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00296-013-2907-9","article-title":"Comparison of national clinical practice guidelines and recommendations on vaccination of adult patients with autoimmune rheumatic diseases","volume":"34","author":"Papadopoulou","year":"2014","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.071_b0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5152\/eurjrheum.2016.16100","article-title":"Vaccination recommendations for adult patients with rheumatic diseases","volume":"3","author":"Durusu Tanr\u0131over","year":"2016","journal-title":"Eur J Rheumatol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.071_b0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.rbr.2014.05.005","article-title":"Evaluation of performance of BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) in a Brazilian cohort of 1,492 patients with spondyloarthritis: data from the Brazilian Registry of Spondyloarthritides (RBE)","volume":"55","author":"da Costa","year":"2015","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.vaccine.2022.05.071_b0095","doi-asserted-by":"crossref","unstructured":"Sim\u00f5es M, Camacho LA, Yamamura AM, Miranda EH, Cajaraville AC, da Silva Freire M. Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies. Biologicals 2012; 40(6):399-404. doi.org\/10.1016\/j.biologicals.2012.09.005.","DOI":"10.1016\/j.biologicals.2012.09.005"},{"issue":"4","key":"10.1016\/j.vaccine.2022.05.071_b0100","doi-asserted-by":"crossref","first-page":"879","DOI":"10.4161\/hv.22982","article-title":"17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study","volume":"9","author":"Martins","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2022.05.071_b0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1590\/S0037-86822009000100006","article-title":"Vaccination against yellow fever among patients on immunosuppressors with diagnoses of rheumatic diseases","volume":"42","author":"Mota","year":"2009","journal-title":"Rev Soc Bras Med Trop"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.071_b0110","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.vaccine.2014.05.040","article-title":"Vaccines and vaccination against yellow fever: WHO Position Paper, June 2013\u2014Recommendations","volume":"33","author":"Who","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.05.071_b0115","doi-asserted-by":"crossref","first-page":"e0149871","DOI":"10.1371\/journal.pone.0149871","article-title":"A single 17D yellow fever vaccination provides lifelong immunity; characterization of yellow-fever-specific neutralizing antibody and T-cell responses after vaccination","volume":"11","author":"Wieten","year":"2016","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.071_b0120","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/art.38960","article-title":"Seroconversion in patients with rheumatic diseases treated with immunomodulators or immunosuppressants, who were inadvertently revaccinated against yellow fever","volume":"67","author":"Oliveira","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.071_b0125","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-14-391","article-title":"Subdoses of 17DD yellow fever vaccine elicit equivalent virological\/immunological kinetics timeline","volume":"14","author":"Campi-Azevedo","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2022.05.071_b0130","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/annrheumdis-2019-215356","article-title":"The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies","volume":"78","author":"McGonagle","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2022.05.071_b0135","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11882-014-0489-6","article-title":"Update on ankylosing spondylitis: current concepts in pathogenesis","volume":"15","author":"Smith","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.vaccine.2022.05.071_b0140","doi-asserted-by":"crossref","unstructured":"Schett G, McInnes IB, Neurath MF. Reframing immune-mediated inflammatory diseases through signature cytokine hubs. N Engl J Med 2021; 385:628-639. https:\/\/doi.org\/10.1056\/NEJMra1909094.","DOI":"10.1056\/NEJMra1909094"},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.071_b0145","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00281-018-0726-5","article-title":"Sex differences in vaccine-induced humoral immunity","volume":"41","author":"Fischinger","year":"2019","journal-title":"Semin Immunopathol"},{"issue":"3","key":"10.1016\/j.vaccine.2022.05.071_b0150","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1590\/S0482-50042013000300003","article-title":"Recomenda\u00e7\u00f5es sobre diagn\u00f3stico e tratamento da espondilite anquilosante","volume":"53","author":"Sampaio-Barros","year":"2013","journal-title":"Rev Bras Reumatol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22007034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22007034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:20:22Z","timestamp":1759404022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22007034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":30,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0264410X22007034"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.05.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Previous biological therapy and impairment of the IFN-\u03b3\/IL-10 axis are associated with low immune response to 17DD-YF vaccination in patients with spondyloarthritis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.05.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}